Quantum Dot-Nucleotide Molecular Beacon for Quantitative CRISPR Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current CRISPR/Cas diagnostics lack quantitative detection methods, relying on sensitive but qualitative molecular beacon approaches that require complex equipment or large reagent quantities, limiting their sensitivity and practicality for high-throughput and resource-limited settings.
Innovation Solution
Development of luminescent and colorimetric quantum dot/nucleic acid hairpin (QD-HP) molecular beacons, utilizing chimeric peptide/peptide nucleic acid (PNA) to conjugate fluorescently labeled DNA or RNA hairpins to ZnS-coated QDs, enabling efficient Forster resonance energy transfer (FRET) and quantitative detection of CRISPR/Cas enzyme activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional fluorophore-quencher molecular beacons are used for CRISPR/Cas detection, then qualitative detection sensitivity is improved, but quantitative detection capability deteriorates and device complexity increases
Solution Approach 1:
The patent transitions from traditional single-color fluorophore-quencher systems to quantum dot-based ratiometric fluorescent systems. This parameter change enables quantitative detection by comparing emission intensities at two different wavelengths (excited and unexcited states), providing both sensitivity and quantitative capability simultaneously through ratio calculation that eliminates variability.
2Measurement precision
If traditional fluorophore-quencher molecular beacons are used, then detection sensitivity is improved, but reagent quantity requirements increase
Solution Approach 1:
The patent employs quantum dots as composite fluorescent markers with unique optical properties. These quantum dot-based molecular beacons provide enhanced brightness and photostability compared to traditional fluorophores, allowing detection with lower reagent quantities while maintaining high sensitivity. The ratiometric nature further amplifies signal strength through dual-wavelength measurement.
3Measurement precision
If traditional molecular beacons are used for CRISPR/Cas detection, then qualitative detection is achieved, but assay complexity and equipment requirements increase
Solution Approach 1:
The patent utilizes the intrinsic ratiometric properties of quantum dots excited at different wavelengths. By measuring emission ratios at two fixed wavelengths (one for excited state, one for unexcited state), the system achieves quantitative detection without requiring complex optical equipment. Standard fluorescence readers can perform the measurements, and the ratio calculation provides robust quantitative data with minimal instrumentation.
4Ease of manufacture
If traditional single-color molecular beacons are used, then assay simplicity is maintained, but multiplexing capability deteriorates
Solution Approach 1:
The patent employs quantum dots with tunable emission wavelengths that can be excited by a single UV source. Different quantum dot sizes emit at different wavelengths, enabling simultaneous detection of multiple targets (multiplexing) in a single assay. The universal UV excitation source simplifies the system while the wavelength-dependent emission provides multiplexing capability, allowing one assay to detect multiple CRISPR/Cas activities or nucleic acid targets.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The QD-HP molecular beacons provide robust, quantitative detection of nucleic acids at picomolar levels without amplification, enabling multiplexing and use in resource-limited settings, such as cell phone-based imaging, with enhanced sensitivity and flexibility for CRISPR/Cas diagnostics.
Implementation Method 1
utilizing chimeric peptide/peptide nucleic acid (PNA) to conjugate fluorescently labeled DNA or RNA hairpins to ZnS-coated QDs, enabling efficient Forster resonance energy transfer (FRET)
Data Source
AI summary
A flexible strategy for assembling luminescent and colorimetric quantum dot/nucleic acid hairpin (QD-HP) molecular beacons for use in CRISPR/Cas diagnostics uses chimeric peptide/peptide nucleic acid (PNA) to conjugate fluorescently labeled DNA or RNA hairpins to ZnS-coated QDs.